Marketing-authorisation holder · Hungary
Celltrion Healthcare Hungary Kft.
99 medicines in 5 countries, as authorisation holder.
Loading your page…
Loading your page…
Marketing-authorisation holder · Hungary
99 medicines in 5 countries, as authorisation holder.
One free account for the Prognia apps: Ward to study, Osler for clinical answers with their sources, and the network to find your colleagues.
Groups are put together by Prognia from the names regulators publish and from company links; they are not an official corporate structure.
Every medicine in the registers under its name, current ones first.
1–25 of 99
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| AVTOZMAConcentrato per soluzione per infusione | Tocilizumab | Italy | Authorised | |
| Avtozma | Tocilizumab | EU (EMA) | Authorised | 2025 |
| Avtozma, 162 mg oplossing voor injectie in een voorgevulde spuit.Oplossing voor injectie | Tocilizumab | Netherlands | Authorised | 2025 |
| AVTOZMA 162 MG SOLUCION INYECTABLE EN JERINGA PRECARGADA162 mg · Solución inyectable en jeringa precargada | Tocilizumab | Spain | Marketed | 2025 |
| AVTOZMA 162 MG SOLUCION INYECTABLE EN PLUMA PRECARGADA162 mg · Solución inyectable en pluma precargada | Tocilizumab | Spain | Marketed | 2025 |
| Avtozma, 20 mg/ml concentraat voor oplossing voor infusie.Concentraat voor oplossing voor infusie | Tocilizumab | Netherlands | Authorised | 2025 |
| AVTOZMA 20 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION20 mg/ml · Concentrado para solución para perfusión | Tocilizumab | Spain | Marketed | 2025 |
| Blitzima | Rituximab | EU (EMA) | Authorised | 2017 |
| Blitzima 100 mg, concentraat voor oplossing voor infusieConcentraat voor oplossing voor injectie of infusie | Rituximab | Netherlands | Authorised | 2017 |
| Blitzima 500 mg concentraat voor oplossing voor infusieConcentraat voor oplossing voor injectie of infusie | Rituximab | Netherlands | Authorised | 2017 |
| EYDENZELTSoluzione iniettabile | Aflibercept | Italy | Authorised | |
| Eydenzelt | Aflibercept | EU (EMA) | Authorised | 2025 |
| Eydenzelt 40 mg/ml oplossing voor injectie in een injectieflaconOplossing voor injectie | Aflibercept | Netherlands | Authorised | 2025 |
| Eydenzelt 40 mg/ml oplossing voor injectie in een voorgevulde spuitOplossing voor injectie | Aflibercept | Netherlands | Authorised | 2025 |
| EYDENZELT 40 MG/ML SOLUCION INYECTABLE EN JERINGA PRECARGADA2 mg · Solución inyectable en jeringa precargada | Aflibercept | Spain | Marketed | 2025 |
| EYDENZELT 40 MG/ML SOLUCION INYECTABLE EN VIAL2 mg · Solución inyectable | Aflibercept | Spain | Marketed | 2025 |
| HERZUMAPolvere per concentrato per soluzione per infusione | Trastuzumab | Italy | Authorised | |
| Herzuma | Trastuzumab | EU (EMA) | Authorised | 2018 |
| Herzuma 150 mg, poeder voor concentraat voor oplossing voor infusiePoeder voor concentraat voor oplossing voor infusie | Trastuzumab | Netherlands | Authorised | 2018 |
| HERZUMA 150 MG POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION150 mg · Polvo para concentrado para solución para perfusión | Trastuzumab | Spain | Marketed | 2018 |
| Herzuma 420 mg poeder voor concentraat voor oplossing voor infusiePoeder voor concentraat voor oplossing voor infusie | Trastuzumab | Netherlands | Authorised | 2018 |
| HERZUMA 420 MG POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION420 mg · Polvo para concentrado para solución para perfusión | Trastuzumab | Spain | Marketed | 2018 |
| OMLYCLOSoluzione iniettabile in penna pre-riempita | Omalizumab | Italy | Authorised | |
| Omlyclo | Omalizumab | EU (EMA) | Authorised | 2024 |
| Omlyclo 150 mg oplossing voor injectie in een voorgevulde penOplossing voor injectie | Omalizumab | Netherlands | Authorised | 2024 |
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current | Past | Companies |
|---|---|---|---|---|
| Netherlands | 34 | 34 | 0 | CompaniesAll medicines |
| Spain | 33 | 33 | 0 | CompaniesAll medicines |
| European Union (EMA) | 17 | 13 | 4 | CompaniesAll medicines |
| Italy | 11 | 11 | 0 | CompaniesAll medicines |
| Romania | 4 | 0 | 4 | CompaniesAll medicines |
Also in the registers of France
The ATC groups most of its medicines belong to, largest first.
The active substances in most of its medicines.
How the registers spell it, normalised: legal forms, accents and capitals removed.
Compiled by Prognia from the public medicine and company registers below. Logos are not used.
Source: European Medicines Agency (EPAR data).
Licence: EMA reuse policy (source acknowledgement required)
Fuente de la información: AEMPS (CIMA).
Licence: AEMPS open data reuse with attribution
Source: BDPM (ANSM, HAS, UNCAM).
Licence: Licence Ouverte v1.0
Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA presentaciones, acquired 11 October 2026 UTC; each source response/update date retained.
Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required
Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA medicamentos, acquired 11 October 2026 UTC; each source response/update date retained.
Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required
BDPM / ANSM, HAS and UNCAM; original URLs and each update date retained
Licence: BDPM exact Licence Ouverte v1.0 (October 2011)
Agenzia Italiana del Farmaco (AIFA); https://drive.aifa.gov.it/farmaci/confezioni_fornitura.csv; HTTP Last-Modified Mon, 12 Oct 2026 23:02:44 GMT; acquired 2026-10-13T17:21:16.224007+00:00; native fields retained, source identifier and role projections are adaptations.
Licence: CC BY 4.0; AIFA published open-data catalog
College ter Beoordeling van Geneesmiddelen, Geneesmiddeleninformatiebank metadata, source update 07-10-2026; downloaded 08-10-2026; factual adaptation.
Licence: Conditional noncreative administrative factual metadata; no dataset-wide CC0 claim
Ministerul Sănătății, Catalogul public naţional al preţurilor, 18 iunie 2021, downloaded 2026-10-08 from data.gov.ro; CC BY 4.0; structured factual adaptation, code whitespace trimmed only where explicitly recorded.
Licence: Creative Commons Attribution 4.0 International (CC BY 4.0)
Report an error or request removalCorrections from the company itself are welcome.
Other companies in the same group.
Ranked by their number of medicines.